Skip to main
HYPR

Hyperfine (HYPR) Stock Forecast & Price Target

Hyperfine (HYPR) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Hyperfine is currently experiencing strong revenue growth and margin improvement, driven by its innovative Swoop MRI technology which has shown high concordance with standard MRI and received accreditation and regulatory approval. With its expanding international presence, strong pipeline for AI-powered software releases, and a business model that generates both upfront equipment revenue and recurring service revenue, the company is well-positioned for future success. However, it faces potential challenges from supplier pricing pressure, regulatory risks, and slow adoption of its technology.

Bears say

Hyperfine is a medical device company with a negative outlook due to competitive risks and slower revenue ramp-up than expected. While the company's technology provides a unique solution for accessing MRIs and has secured several regulatory clearances, it faces challenges in gaining market share in a highly competitive industry dominated by larger players. Additionally, the company's revenue growth has been slower than expected, with higher international sales mix driving down average selling prices. These factors may hinder the company's ability to meet its revenue and cash burn guidance, making it a risky investment at this time.

Hyperfine (HYPR) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hyperfine and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hyperfine (HYPR) Forecast

Analysts have given Hyperfine (HYPR) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Hyperfine (HYPR) has a Strong Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.03, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.03, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hyperfine (HYPR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.